Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults

Journal of Medicinal Food

Volumn 14, Issue 1-2, 2011, Pages 79-85

  Nova, Esther ^a   Viadel, Blanca ^b   Wärnberg, Julia ^a   Carreres, Jose E ^b   Marcos, Ascensión ^a  

^a INSTITUTE OF FOOD SCIENCE   (Spain)

^b Centro Tecnologico Ainia   (Spain)

Author keywords

adhesion molecules; bowel habits; gastrointestinal symptoms; immunomodulation; inflammatory proteins; lymphocyte subsets; probiotic bacteria

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CERULOPLASMIN; FRUCTOSE OLIGOSACCHARIDE; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; PLACEBO; SYMBYO; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BLOATING; CERULOPLASMIN BLOOD LEVEL; CHRONIC DIARRHEA; COLONY FORMING UNIT; CONSTIPATION; DEFECATION HABIT; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPEPSIA; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; GENERAL CONDITION IMPROVEMENT; HEALTH STATUS; HUMAN; HUMAN CELL; IMMUNE STATUS; IMMUNOMODULATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PARACASEI; LACTOSE INTOLERANCE; LYMPHOCYTE SUBPOPULATION; MACRONUTRIENT; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; PHAGOCYTOSIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS THERMOPHILUS; TREATMENT RESPONSE; WELLBEING;

ADULT; BIFIDOBACTERIUM; DIGESTION; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRACT; HEALTH STATUS; HUMANS; IMMUNE SYSTEM; LACTOBACILLUS; MALE; MIDDLE AGED; OLIGOSACCHARIDES; SELF ADMINISTRATION; STREPTOCOCCUS THERMOPHILUS; SYNBIOTICS;

BIFIDOBACTERIUM ANIMALIS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PARACASEI; STREPTOCOCCUS THERMOPHILUS;

EID: 79952083516     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0328     Document Type: Article

References (38)

1. Food and Agriculture Organization/World Health Organization: Expert Consultation Report: Health and Nutritional Properties of Probiotics in Food Including Powder Milk and Live Lactic Acid Bacteria.Argentina.October 2001.www.fao.org/es/ESN/Probio/ report.pdf (accessed August 27, 2007).
2. Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-1412.
3. Scherezenmeir J, De Vrese M: Probiotics, prebiotics and synbiotics - approaching a definition. Am J Clin Nutr 2001;73 (2 Suppl):361S-364S.
4. Duggan C, Gannon J, Walker WA: Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 2002;75:789-808. (Pubitemid 34441247)
5. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H: Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993;105:1643-1650. (Pubitemid 24002779)
6. Walker WA: Role of nutrients and bacterial colonization in the development of intestinal host defense. J Pediatr Gastroenterol Nutr 2000;30(Suppl 2):S2-S7.
7. Nova E, Toro O, Varela P, Lopez-Vidriero I, Morande G, Marcos A: Effects of a nutritional intervention with yogurt on lymphocyte subsets and cytokine production capacity in anorexia nervosa patients. Eur J Nutr 2006;45:225-233. (Pubitemid 43781448)
8. Lu L, Walker WA: Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 2001;73:1124S-1130S.
9. Roberfroid MB: Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 2000;71(6 Suppl):1682S-1687S.
10. Kanamori Y, Hashizume K, Sugiyama M, Mortomi M, Yuki N, Tanaka R: A novel synbiotic therapy dramatically improved the intestinal function of a pediatric patient with laryngotracheo-esophageal cleft (LTEC) in the intensive care unit. Clin Nutr 2002;21:527-530. (Pubitemid 35446853)
11. Jain PK, McNaught CE, Anderson AD, MacFie J, Mitchell CJ: Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 2004;23:467-475. (Pubitemid 39107024)
12. Bengmark S: Use of some pre-, pro- and synbiotics in critically ill patients. Best Pract Res Clin Gastroenterol 2003;17:833-848.
13. Kanamori Y, Hashizume K, Sugiyama M, Morotomi M, Yuki N: Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Dig Dis Sci 2001;46:2010-2016.
14. Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R: Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 2004;39:1686-1692. (Pubitemid 39488000)
15. Haskey N, Dahl WJ: Synbiotic therapy: a promising new adjunctive therapy for ulcerative colitis. Nutr Rev 2006;64:132-138.
16. Macfarlane S, Furrie E, Kennedy A, Cummings JH, Macfarlane GT: Mucosal bacteria in ulcerative colitis. Br J Nutr 2005;93(Suppl 1):S67-S72. (Pubitemid 43073410)
17. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA, Macfarlane GT: Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005;54:242-249. (Pubitemid 40139241)
18. Olah A, Belagyi T, Poto L, Romics L Jr, Bengmark S: Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology 2007;54:590-594. (Pubitemid 46724735)
19. Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, Jan CM, Lai CH, Wang TN, Wang WM: Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004;80:737-741.
20. Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS: Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 2000;54:849-855.
21. Parra MD, Martínez de Morentin BE, Cobo JM, Mateos A, Martínez JA: Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J Physiol Biochem 2004;60:85-91.
22. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT: Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 2005;40:28-37. (Pubitemid 40053456)
23. Meyer AL, Micksche M, Herbacek I, Elmadfa I: Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women. Ann Nutr Metab 2006;50:282-289. (Pubitemid 43829820)
24. Mearin F, Badía X, Balboa A, Benavent J, Caballero AM, Domínguez-Muñoz E, Garrigues V, Piqué JM, Roset M, Cucala M, Figueras M; the RITMO Group: Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Aliment Pharmacol Ther 2006;23:815-826. (Pubitemid 43344601)
25. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E: Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol 2001;8:293-296. (Pubitemid 32217059)
26. Pregliasco F, Anselmi G, Fonte L, Giussani F, Schieppati S, Soletti L: A new chance of preventing winter diseases by the administration of synbiotic formulations. J Clin Gastroenterol 2008;42(Suppl 3 Pt 2):S224-S233.
27. De Paula JA, Carmuega E, Weill R: Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam 2008;38:16-25.
28. Cherbut C: Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 2003;62:95-99.
29. Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI, Kuwahara A: Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 2008;59(Suppl 2):251-262.
30. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ: Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235-243. (Pubitemid 44309560)
31. Nancey S, Bienvenu J, Coffin B, Andre F, Descos L, Flourié B: Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. Dig Dis Sci 2002;47:921-928. (Pubitemid 34286892)
32. van Nuenen MH, de Ligt RA, Doornbos RP, van der Woude JC, Kuipers EJ, Venema K: The influence of microbial metabolites on human intestinal epithelial cells and macrophages in vitro. FEMS Immunol Med Microbiol 2005;45:183-189. (Pubitemid 41040001)
33. Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203. (Pubitemid 37377790)
34. Pradhan AD, Rifai N, Ridker PM: Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 2002;106:820-825.
35. Malik I, Danesh J, Whineup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D: Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001;358:971-976.
36. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, Elkhalil L, Fruchart JC, Ducimetiere P; PRIME Study Group: Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 2003;170:169-176. (Pubitemid 37083576)
37. Angulo S, Llopis M, Antolin M, Gironella M, Sans M, Malagelada JR, Piqué JM, Guarner F, Panés J: Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2006;291:G1155-G1162. (Pubitemid 44904170)
38. Corthésy B, Gaskins HR, Mercenier A: Cross-talk between probiotic bacteria and the host immune system. J Nutr 2007;137 (3 Suppl 2):781S-790S.